Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

BNT162b2 COVID-19 vaccination elicits the expansion of CD16+CD8+ T cells endowed with natural killer cell features

Journal of Allergy and Clinical Immunology(2025)10.1016/j.jaci.2025.01.024Source: DataRank Database

BNT162b2 COVID-19 vaccination elicits the expansion of CD16+CD8+ T cells endowed with natural killer cell features is a research paper published in Journal of Allergy and Clinical Immunology (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: hybridTopics (18)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (19)

Fabiana Drommi,Alessia Calabrò,Cirino Botta ORCID,Giacomo Sidoti Migliore ORCID,Paolo Carrega ORCID

Live enrichment

PubMed:23304386

Ministero della Salute

Grant: PNRR-MAD-2022-12375909

Associazione Italiana per la Ricerca sul Cancro

Grant: IG 25023

Associazione Italiana per la Ricerca sul Cancro

Grant: IG 30453

Ministero dell'Istruzione dell'Università e della Ricerca

Grant: unidentified

unidentified

hybridLicense: cc-by

publisherhttps://doi.org/10.1016/j.jaci.2025.01.024

publisherhttps://api.elsevier.com/content/article/PII:S0091674925001125?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0091674925001125?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12145267/

repositoryhttps://hdl.handle.net/11567/1280919

Fields of Study

03 medical and health sciences0302 clinical medicine

Keywords

AdultMaleADCC; BNT162b2 mRNA vaccine; CD16/FcγRIIIA; NK cells; human; innate-like T cells; spike-specific CD8(+) T cellsCOVID-19 VaccinesSARS-CoV-2Receptors, IgGVaccinationADCC, BNT162b2 mRNA vaccine, CD16/ FcγRIIIA, Human, Innate-like T cells, NK cells, Spike-specific CD8+ T cellsCOVID-19CD8-Positive T-LymphocytesMiddle AgedGPI-Linked ProteinsKiller Cells, NaturalHumansFemaleBNT162 Vaccine